China’s Tech Stocks Are Falling Despite Their Own Breakthroughs

BREAKING news from the Chinese stock market: listed AI companies are falling on their own breakthroughs. Yes, Moonshot can roll out Kimi K3 and the market responds as if the company had announced a new kind of damp squib. The reason, if you can bear it, is that these labs have open-weighted their models so thoroughly that nobody needs to pay a premium for them. There was a time when a frontier model was treated like the philosopher's stone; now it is more like the world's most impressive loss leader. In other words, the industry's grand strategy is to make itself uninvestable through sheer generosity.

The mechanics are almost beautiful in their futility. Open-weight models strip the model layer of its pricing power, which is corporate-speak for 'we gave away the crown jewels and now everyone is using them for free.' A frontier-class Chinese model runs at a fraction of the Western list price, which sounds like a bargain for users and a slow-motion death sentence for anyone holding the stock. Investors who bought the dream are now being asked to appreciate the aesthetic of commoditised intelligence rather than dividends. The labs have essentially become charities that occasionally remember they are supposed to be companies, and the market is not laughing along.

One must salute the symmetry at work. Western giants hoard their weights behind API gates and charge rents, while Chinese labs hand over the equivalent goods at a discount and watch investors flee. Moonshot may have delivered the future, but it has delivered it at a markdown, and the stock market is returning the favour. At this rate, the only premium left in Chinese AI will be paid to electric utilities, and the only thing falling faster than the share price is the list price itself. That such a sector can be simultaneously brilliant and uninvestable is a genuinely impressive feat — the sort of achievement that deserves its own award ceremony, with no premium pricing on the tickets.